Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 86.91B | 86.28B | 78.15B | 77.34B | 68.31B | 62.88B |
Gross Profit | 20.57B | 19.47B | 17.26B | 16.92B | 14.86B | 13.83B |
EBITDA | 4.71B | 4.87B | 4.97B | 4.86B | 3.28B | 3.06B |
Net Income | 3.23B | 2.60B | 2.83B | 2.72B | 1.71B | 1.54B |
Balance Sheet | ||||||
Total Assets | 85.08B | 65.20B | 62.68B | 55.19B | 50.02B | 47.71B |
Cash, Cash Equivalents and Short-Term Investments | 15.79B | 10.54B | 9.32B | 6.96B | 9.78B | 8.12B |
Total Debt | 29.49B | 14.03B | 12.76B | 8.60B | 2.04B | 1.16B |
Total Liabilities | 58.70B | 40.71B | 40.50B | 36.43B | 35.97B | 35.69B |
Stockholders Equity | 26.28B | 24.38B | 22.14B | 18.72B | 14.02B | 12.01B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 1.74B | -1.37B | -8.83B | 989.56M | 4.08B |
Operating Cash Flow | 0.00 | 2.81B | -195.45M | -7.03B | 1.85B | 5.03B |
Investing Cash Flow | 0.00 | -2.19B | -1.72B | -3.29B | -1.28B | -1.14B |
Financing Cash Flow | 0.00 | 337.58M | 4.14B | 6.32B | 615.13M | -1.53B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | ¥41.65B | 22.22 | 1.10% | 22.71% | 84.60% | ||
77 Outperform | ¥21.37B | 47.11 | 5.09% | -4.78% | -75.47% | ||
73 Outperform | ¥38.77B | 21.25 | 1.51% | 17.19% | 23.23% | ||
72 Outperform | ¥41.10B | 13.32 | 2.50% | 9.06% | -5.33% | ||
64 Neutral | $10.75B | 15.69 | 7.62% | 2.01% | 2.75% | -15.14% | |
63 Neutral | ¥28.39B | 63.07 | 3.23% | 3.42% | -120.51% | ||
49 Neutral | ¥8.27B | 67.23 | 6.22% | 9.20% | -383.70% |